CA2140389A1 - Guiding introducer system for use in left atrium - Google Patents
Guiding introducer system for use in left atriumInfo
- Publication number
- CA2140389A1 CA2140389A1 CA002140389A CA2140389A CA2140389A1 CA 2140389 A1 CA2140389 A1 CA 2140389A1 CA 002140389 A CA002140389 A CA 002140389A CA 2140389 A CA2140389 A CA 2140389A CA 2140389 A1 CA2140389 A1 CA 2140389A1
- Authority
- CA
- Canada
- Prior art keywords
- guiding introducer
- section
- distal end
- introducer
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0041—Catheters; Hollow probes characterised by the form of the tubing pre-formed, e.g. specially adapted to fit with the anatomy of body channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
Abstract
A guiding introducer system for use in the left atrium comprised of an inner guiding introducer and an outer guiding introducer wherein the inner guiding introducer is comprised of a first and second section and the outer guiding introducer is comprised of a first and second sections. The guiding introducer system is for use in sensing, pacing, and ablating procedures within the left atrium of the human heart.
Description
p tl¢~
~ ~ 4 0 3 8 9 EF5485 1 327;US
(a) Title of Invention GUIDING INTRODUCER SYSTEM FOR USE IN THE LEFT ATRIUM
(b) This application is a continuation-in-part of application Serial No. 08/147,168, filed November 3, 1993.
(c) Background of Invention 1. Field of Invention This invention relates to introducers. More particularly, this invention relates to a guiding introducer system for use within the left atrium of the human heart.
~ ~ 4 0 3 8 9 EF5485 1 327;US
(a) Title of Invention GUIDING INTRODUCER SYSTEM FOR USE IN THE LEFT ATRIUM
(b) This application is a continuation-in-part of application Serial No. 08/147,168, filed November 3, 1993.
(c) Background of Invention 1. Field of Invention This invention relates to introducers. More particularly, this invention relates to a guiding introducer system for use within the left atrium of the human heart.
2. Prior Art Introducers and catheters have been in use for medical procedures for many years. For example, one use has been to convey an electrical stimulus to a selected location within the human body. Another use is the monitoring of measurements for diagnostic tests within the human body. Thus, catheters may be used by a physician to ex~m;ne, diagnose and treat while positioned at a specific location within the body which are otherwise inaccessible without more invasive procedures. Catheters may be inserted into a major vein or artery which is near the body surface. The catheters are then guided to the specific location for e~m;nAtion, diagnosis or treatment by manipulating the catheter through the artery or vein of the human body.
Catheters have become increasingly useful in remote and difficult to reach locations within the body. However, the utilization of these catheters is frequently limited because of the need for the precise placement of the tip of the catheter at a specific location within the body.
2l4o389 Control of the movement of catheters to achieve such precise placement is difficult because of the inherent structure of a catheter. The body of a conventional catheter is long and tubular.
To provide sufficient control of the movement of the catheter, it is necessary that its structure be somewhat rigid. However, the catheter must not be so rigid as to prevent the bending or curving necessary for movement through the vein, artery or other body part to arrive at the specified location. Further, the catheter must not be so rigid as to cause damage to the artery, vein or body part while it is being moved within the body.
While it is important that the catheter not be so rigid as to cause injury, it is also important that there be sufficient rigidity in the catheter to accommodate torque control, i.e., the ability to transmit a twisting force along the length of the catheter. Sufficient torque control enables controlled maneuverability of the catheter by the application of a twisting force at the proximal end of the catheter that is transmitted along the catheter to its distal end. The need for greater torque control often conflicts with the need for reduced rigidity to prevent injury to the body vessel.
Catheters are used increasingly for medical procedures involving the human heart. In these procedures a catheter is typically advanced to the heart through veins or arteries and then is positioned at a specified location within the heart. Typically, the catheter is inserted in an artery or vein in the leg, neck, upper chest or arm of the patient and threaded, often with the aid _ ~1'103~q of a guidewire or introducer, through various arteries or veins until the tip of the catheter reaches the desired location in the heart.
The distal end of a catheter used in such a procedure is sometimes preformed lnto a desired curvature so that by torqulng the catheter about lts longitudinal axis, the catheter can be manlpulated to a desired locatlon wlthln the heart or ln the arteries or veins associated with the heart. For example, U.S.
Patent No. 4,882,777 dlscloses a catheter with a complex curvature at its distal end for use in a specific procedure in the right ventrlcle of a human heart. U.S. Patent No. 5,231,994 dlscloses a guide catheter for gulding a balloon catheter for the dilation of coronary arteries. U.S. Patent No. 4,117,836 discloses a catheter for the selective coronary angiography of the left coronary artery and U.S. Patent Nos. 5,299,574, 5,215,540, 5,016,640 and 4,883,058 disclose catheters for use in selective coronary angiography of the right coronary artery. See also U.S. Patent No. 4,033,031.
Finally, U.S. Patent No. 4,898,591 discusses a catheter with inner and outer layers containing braided portlons. The '591 patent also discloses a number of different curvatures for intravascular catheters.
In addition to single catheters with various curvatures, U.S. Patent No. 4,581,017 dlscloses an inner and outer guide catheter, (numbers 138 and 132), for use with a balloon catheter for treatment of coronary arteries. U.S. Patent No. 5,267,982 discloses a catheter assembly and methods for catheterization of A~
., coronary arteries wherein an inner catheter (50) and outer catheter (52) are used in combination for the treatment of right and left coronary angiographic procedures. See also U.S. Patent No.
4,935,017 which discloses a similar device. U.S. Patent No.
5,290,229 discloses a straight outer sheath and a preformed inner catheter for use in the heart. See also U.S. Patent Nos.
5,304,131, 5,120,323, 4,810,244 and 5,279,546.
Thus, there are a number of patents which disclose catheters with predetermined shapes, designed for use in specific medical procedures generally associated with the heart or the vascular system. Because of the precise physiology of the heart and the vascular system, catheters or introducers with carefully designed shapes for predetermined uses within the human heart and vascular system are important.
The sources of energy used for catheter ablation vary.
Initially, high voltage, direct current (DC) ablation techniques were commonly used. However, because of problems associated with the use of DC current, radio frequency (R.F.) ablation has become a preferred source of energy for the ablation procedures. The use of RF energy for ablation has been disclosed, for example, in U.S.
Patent Nos. 4,945,912, 5,209,229, 5,281,218, 5,242,441, 5,246,438, 5,281,213 and 5,293,868. Other energy sources being considered for ablation of heart tissue include laser, ultrasound, microwave and direct current fulgutronization procedures. Also disclosed have been procedures where the temperature about the catherization probe is modified.
Catheter ablation of accessory pathways associated with Wolfe-Parkinson-White syndrome using a long vascular sheath by both a transseptal and retrograde approach is discussed in Saul, J.P., et al. "Catheter Ablation of accessory Atrioventricular Pathways in Young Patients: Use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approach" Journal of the American College of Cardiology, Vol. 21, no. 3, pps. 571-583 (March 1, 1993). See also Swartz, J.F. "Radiofrequency Endocardial Catheter Ablation of Accessory Atrioventricular Pathway Atrial Insertion Sites" Circulation, Vol. 87, no. 2, pps. 487-499 (February, 1993).
Accordingly, it is an object of this invention to prepare a dual guiding introducer system for selected medical procedures in the left atrium.
It is a further object of this invention to prepare a dual guiding introducer system for use in selected electrophysiology procedures within the left atrium of the heart.
Another object of this invention is to prepare a dual guiding introducer system for use in selected ablation procedures within the left atrium of the heart.
These and other objects are obtained by the design of the guiding introducer system disclosed in the instant invention.
(d) Summary of Invention The instant invention is a guiding introducer system for selected medical procedures in the left atrium. It is comprised of an inner guiding introducer and an outer guiding introducer. A
dilator is preferably used with the guiding introducer system, which dilator may be a transseptal dilator used with a Brockenbrough needle. The inner guiding introducer is a shaped introducer comprised of a first and second section, wherein the first section is a generally elongated straight section which is merged at its distal end with the second section which is a simple curved section. The outer guiding introducer is comprised of a first and second sections, wherein the first section is a generally elongated straight section which is merged at its distal end with the second section which forms a complex curved section. The inner guiding introducer is longer than the outer guiding introducer to permit it to extend out from the lumen of the outer guiding introducer to form various curves and shapes.
(e) Brief Description of the Drawings Figure 1 is a cross-section of the left side of the heart showing the mitral valve and the placement of the guiding introducer system.
Figure 2 is a perspective view of the preferred dilator.
Figure 3 is a perspective view of the inner guiding introducer.
Figure 4 is a perspective view of the outer guiding introducer.
Figure 5 is a perspective view of the inner and outer guiding introducers in combination with the distal end of the inner guiding introducer extended from the distal end of the outer guiding introducer.
-(f) Detailed Description of the Drawings.
A typical human heart includes a right ventricle, a right atrium, left ventricle and left atrium. The right atrium is in fluid commlln;cation with the superior vena cava and the inferior vena cava. The atrioventricular septum separates the right atrium from the right ventricle. The tricuspid valve contained within the atrioventricular septum COmmlln; cates the right atrium with the right ventricle. On the inner wall of the right atrium where it is connected with the left atrium is a recessed portion, the fossa ovalis. See Figure 1. In the heart of a fetus, the fossa ovalis is open, permitting the fetal blood to flow between the right and left atria. In most individuals, this opening closes after birth, but in as many as 25 percent of individuals an opening still remains in the fossa ovalis between the right and left atria.
Between the fossa ovalis and the tricuspid valve is the opening or ostium for the coronary sinus. The coronary sinus is the large epicardial vein which accommodates most of the venous blood which drains from the myocardium into the right atrium.
In the normal heart, contraction and relaxation of the heart muscle (myocardium) takes place in an organized fashion as electro-chemical signals pass sequentially through the myocardium from the atrial to the ventricular tissue along a well defined route which includes the His-Purkinje system. Initial electrical impulses are generated at the sinuatrial (SA) node and conducted to the atrioventricular (AV) node. The AV node lies near the ostium of the coronary sinus in the interatrial septum in the right atrium.
21~038~
The His-Purkinje system begins at the AV node and follows along the membranous interatrial septum toward the tricuspid valve through the atrioventricular septum and into the membranous interventricular septum. At about the middle of the interventricular septum, the His-Purkinje system splits into right and left branches which straddle the summit of the muscular part of the interventricular septum.
Sometimes abnormal rhythms occur in the heart which are referred to as arrhythmia. For example, a common arrhythmia is Wolfe-Parkinson-White syndrome (W-P-W). The cause of W-P-W is generally believed to be the existence of an anomalous conduction pathway or pathways that connects the atrial muscle tissue directly to the ventricular muscle tissue, thus by-passing the normal His-Purkinje system. These pathways are usually located in the fibrous tissue that connects the atrium and the ventricle. In recent years a technique has been developed to destroy these anomalous conduction pathways by delivering energy into the tissue in which the pathways exist. To accomplish this procedure a special electrode catheter is positioned as close as possible to the anomalous conduction pathway to maintain constant tissue contact while energy is delivered to the cardiac tissue to destroy the pathway. This same type of contact with the cardiac tissue is also necessary when mapping or other such procedures are employed relating to these pathways.
One end of these anomalous conduction pathways can be located either in the right atrium or in the left atrium with the other end ~140389 of the pathway located in the corresponding ventricle. When the anomalous conduction pathway is located between the left atrium and the left ventricle, there are two approaches to positioning the catheter near the pathway for the appropriate medical procedure.
One is to introduce the catheter into the femoral artery by a standard introducer sheath and advance it up the aorta, across the aortic valve into the left ventricle and then attempt to position its tip under the mitral valve annulus near the anomalous conduction pathway. This approach is frequently difficult for many reasons, including the structure of the left ventricle, the fact that it requires arterial access and potential problems associated with ablation of ventricular tissue such as the creation of a substrate for a future arrhythmia which could result in sudden cardiac death. The other approach is to introduce a transseptal sheath apparatus, a long single plane curve introducer, into the right femoral vein and advance it through the inferior vena cava into the right atrium. A puncture is then made through the fossa ovalis in the interatrial septum and the apparatus is advanced into the left atrium where the trocar and dilator of the apparatus are removed, leaving the introducer in position in the left atrium.
The mapping or ablation catheter is then inserted through the introducer and into the left atrium and positioned on top of the mitral valve annulus near the anomalous conduction pathway.
Specific positions may be chosen for the mapping or ablation on the left side of the heart, including specifically posteroseptal, posterior, posterolateral, lateral and anterolateral positions "` 2140389 around the mitral valve annulus.
Traditionally, there have been two techniques for locating and ablating anomalous conduction pathways which are situated between the right atrium and right ventricle. Either method can be initiated by advancing a catheter through an access site into a vein in the leg, neck or upper chest.
The first technique, which approaches the pathway from the pathway's ventricular insertion site, involves entering the right atrium from either the inferior or superior vena cava, passing through the tricuspid valve, and advancing toward the apex of the right ventricle. Then the catheter is directed to make a 180 degree turn to reverse its path back up toward the right atrium and locate the accessory pathway under the tricuspid valve apparatus.
The accessory pathway is then ablated from the ventricular insertion site under the tricuspid valve.
The second technique, which approaches the pathway from the atrial insertion site, is to enter the right atrium from the inferior or superior vena cava, and attempt to locate the atrial insertion site of the accessory pathway around the tricuspid valve annulus. The accessory pathway is then ablated from the pathway's atrial insertion site on the atrial aspect of the tricuspid valve.
AV nodal pathways can be located and ablated from the right atrium.
Mere introduction of the catheter into the left atrium is not sufficient to effectively and efficiently perform these medical procedures, especially the mapping or ablation of anomalous ~l l L1 C) 389 conduction pathways. These medical procedures are usually performed using a specific catheter. The medical practitioners monitor the introduction of the catheter and its progress through the vascular system by a fluoroscope. However, such fluoroscopes do not easlly identify the specific features of the heart in general and the critically important structures of the left atrium in specific, thus making placement of the catheter difficult.
This placement is especially difficult as the beating heart is in motion and the catheter will be moving within the left atrium as blood is being pumped through the heart throughout the procedure.
The structure and shape of the guiding introducer of the instant inventlon addresses and solves these problems.
The guiding introducer system for use ln the left atrium is comprised of an inner and an outer guiding introducer. See Figure 5. A dilator is also preferably used wherein the dilator may be a transseptal dilator used with cardiac procedures requiring a Brockenbrough needle for a transseptal puncture and is generally curved. See Flgure 2. Generally the dlstal end is curved in a curve with a radius of about 3.0 to 4.0 in. with an arc of about 20 to about 40 degrees ending in a conventional distal tip. The standard length of the dilator is about 60 to about 80 cm. Alternatively, a different dilator may be used without a Brockenbrough needle.
The inner guiding introducer ls generally comprlsed of two sectlons. See Flgure 3. The first sectlon is a conventional generally elongated hollow straight catheter section of sufficient length for introduction lnto the patient and for manipulation from ~i' ~1~389 the point of lnsertlon to the speclfic deslred location wlthln the heart. Merged wlth the distal end of the flrst section of the guiding introducer, but an lntegral part of the entlre guldlng lntroducer, ls the second sectlon which ls a curved sectlon, curved ln a simple curve wlth a radlus of about 0.5 to about 2.0 ln., preferably about 0.7 to about 1.3 ln. to form an arc of approximately 150 to about 270 degrees, preferably about 170 to about 190 degrees endlng ln a dlstal tlp.
The outer guldlng lntroducer for use ln the left atrium is comprised of a first and second sections. See Figure 4. ~As with the inner guiding introducer, this divlsion into two separate sections is for ease of illustratlon. The gulding introducer is preferably formed in a single procedure with each section an integral part of the overall guiding introducer.) The flrst section ls a conventional, generally elongated hollow straight catheter section of sufflclent length for lntroductlon lnto the patient and for manlpulatlon from the polnt of insertion to the speclflc deslred locatlon wlthln the heart. Merged wlth the dlstal end of the flrst sectlon of the guldlng lntroducer ls the second sectlon whlch ls comprlsed of a compound curved sectlon curvlng both upward and to the rlght (as shown ln Flgure 4). This curved sectlon flrst curves upward ln a curve wlth a radius of about 0.3 to about 0.7 in. with an arc of approximately 40 to about 60 degrees, preferably about 45 to about 55 degrees. At the same tlme as the curved sectlon curves upward, it also curves to the rlght ln a slmple curve wlth a radlus of from about 0.70 to about 1.30 in. and preferably from about 0.80 to about 1.20 ln.
~ 1~038q with an arc of about 30 degrees to about 60 degrees, and preferably from about 40 degrees to about 50 degrees, endlng ln the distal tip of the outer gulding lntroducer.
By extendlng the dlstal tlp of the lnner guldlng introducer away from the dlstal tlp of the outer guldlng lntroducer and by rotatlng the lnner guldlng lntroducer wlth respect to the outer guldlng lntroducer, a varlety of shapes of the overall guldlng lntroducer system are formed to dlrect the mapplng and/or ablatlon catheter toward the site wlthln the atrlum of lnterest. See Flgure 5. These shapes permlt ablatlon procedures wlthln the left atrium to be performed, for example, around the mltral valve annulus ln varlous posltlons such as anterior to anterolateral to lateral to posterolateral to posteroseptal to septal. The various locatlons can be treated by extendlng the inner guldlng introducer further from the outer guidlng lntroducer whlch forms a dlfferent overall shape and/or by rotatlng the lnner guldlng lntroducer wlth respect to the outer guidlng lntroducer. In addltlon, by manlpulatlon of the lnner guidlng introducer withln the outer guiding introducer, additional procedures can be performed withln the left atrlum, for example, for treatment of ectoplc atrial tachycardia or even for certain atrlal flbrlllatlon procedures. Belng able to extend the lnner guidlng introducer withln the outer guiding introducer and to rotate the lnner guldlng introducer within the outer guldlng lntroducer permlts a wlde varlety of overall shapes, whlch ls 69208-4g ~!
~1~0389 particularly useful to the medical practitioners. The medical practitioner is able to determine the relative location of the inner and outer guiding introducers because of tip markers located near the distal tip of both the inner and outer guiding introducers.
The distal tip of both the inner and outer guiding introducers may be, and generally will be, tapered to form a good transition with the dilator.
The relative size of the outer guiding introducer in relation to the inner guiding introducer should be sufficient to permit the inner guiding introducer to be torqued or rotated within the outer guiding introducer without undue restriction on such movement.
Preferably, the difference in size between the inner and outer guiding introducer should be at least about 3 "French" (1 French equals about one-third of a millimeter). For example in one preferred embodiment, the outer guiding introducer is 11 French in size and the inner guiding introducer is 8 French. By this difference in diameter, there is approximately 1 French unit of volume available between the outer surface of the inner guiding introducer and the inner surface of the outer guiding introducer.
Preferably, this volume of space between the inner and outer guiding introducer is filled with a biocompatible solution, such as a saline solution, preferably a heparinized saline solution. This saline solution also provides lubricity to the two guiding introducers, allowing more accurate torquing of the inner guiding introducer within the outer guiding introducer. In addition, it is 214~389 preferable that the structure of both the inner and the outer guiding introducer have a high torsional constant to allow for the full utilization of the various shapes available by rotation and extension of the inner and outer guiding introducer. To permit this high torsional constant, in one preferred embodiment the inner guiding introducer is braided to provide further strength and structural stability.
The guiding introducer may be made of any material suitable for use in humans, which has a memory or permits distortion from and subsequent substantial return to the desired three dimensional or complex multi-planar shape. For the purpose of illustration and not limitation, the internal diameter of the tip of the guiding introducers may vary from about 6 to about 10 "French" Such guiding introducers can accept dilators from about 6 to about 10 French and appropriate guidewires. Obviously if larger, or smaller dilators and catheters are used in conjunction with the guiding introducers of the instant invention, modification can be made in the size of the instant guiding introducers.
The pair of guiding introducers preferably contain one or a multitude of radiopaque tip marker bands near the distal tip of the guiding introducers. Various modifications may be made in the shapes by increasing or decreasing its size or adding additional tip markers.
The inner and outer guiding introducers also preferably contain one or a plurality of vents near the distal tip of the guiding introducers, preferably 3 or 4 or such vents. The vents 038~
are preferably located no more than about 5 to 6 cm. from the tip of the guiding introducers and more preferably 0.5 cm. to about 4.0 cm. from the tip. The size of these vents should be in the range of about 20 to 60 1/1000 of an inch in diameter. These vents are generally designed to prevent air embolisms from entering the guiding introducers caused by the withdrawal of a catheter contained within the guiding introducers in the event the distal tip of one of the guiding introducers is occluded. For example, if the tip of the inner guiding introducer is placed against the myocardium and the catheter located within the inner guiding introducer is withdrawn, a vacuum may be created within the inner guiding introducer if no vents are provided. If such vacuum is formed, air may be forced back into the guiding introducer by the reintroduction of a catheter into the lumen of the guiding introducers. Such air embolism could cause problems to the patient including the possibility of a stroke, heart attack or other such problems common with air embolisms in the heart. The addition of vents near the distal tip of the guiding introducers prevents the formation of such vacuum by permitting fluid, presumably blood, to be drawn into the lumen of the guiding introducers as the catheter is being removed, thus preventing the possibility of formation of an air embolism.
Variances in size or shape of the pair of guiding introducers are also intended to encompass pediatric uses for the pair of guiding introducers of the instant invention, although the preferred use is for adult human hearts. It is well recognized 2i~0389 .~
that pediatric uses may require reductions in size of the various sections of the guiding introducers in particular the first section, but without any significant modification to the shape or curves of the guiding introducers. However, because incremental changes can be made in the overall shape of the pair of guiding introducers, the system can better adjust to differing shapes and sizes of heart than can a single guiding introducer.
In operation, a modified Seldinger technique is normally used for the insertion of a catheter into either an artery or vein of the body. Using this procedure, a small skin incision is made at the appropriate location to facilitate the catheter and dilator passage. The subcutaneous tissue is then dissected, followed by a puncture of the vessel with an appropriate needle with stylet positioned at a relatively shallow angle. The needle is then partially withdrawn and reinserted at a slightly different angle into the vessel, making sure that the needle remains within the vessel. A soft flexible tip of an appropriate sized guidewire is then inserted through and a short distance beyond the needle into the vessel. Firmly holding the guidewire in place, the needle is removed. The guidewire is then advanced through the vessel into the right atrium. With the guidewire in place, the dilator is then placed over the guidewire with the pair of guiding introducers placed over the dilator. The dilator and pair of guiding introducers generally form an assembly to be advanced together along the guidewire into the right atrium. After insertion of the assembly, the guidewire is then withdrawn. A Brockenbrough or 21~0389 -trocar needle is then inserted through the lumen of the dilator to the right atrium to be used to create an opening through the interatrial septum, preferably at the fossa ovalis. The tip rests against the intraatrial septum at the level of the fossa ovalis.
The Brockenbrough needle is then advanced within the dilator to reach the fossa ovalis. After the opening is made through the interatrial septum, the needle, dilator and pair of guiding introducers are advanced into the left atrium. After the pair of guiding introducers are advanced through the interatrial septum into the left atrium, the Brockenbrough or trocar and dilator are removed, leaving the pair of guiding introducers in the left atrium. The catheter to be used for analysis and/or treatment of the anomalous conduction pathways is then advanced through the lumen of the pair of guiding introducers and is placed at an appropriate location near the mitral valve annulus. By extending and withdrawing the inner guiding introducer from the outer guiding introducer and by rotating the inner guiding introducer within the outer guiding introducer, great variances in the overall shape of the guiding introducer system can be achieved.
By movement of the inner guiding introducer within the outer guiding introducer in conjunction with fluoroscopic viewing, the distal portion of the outer guiding introducer can be manipulated to direct the distal end of a catheter placed within the lumen of the inner guiding introducer to a specific internal surface within the left atrium. See Figure 5. In addition, by providing sufficient rigidity, the distal end of the inner guiding catheter 21g~389 can be maintained in that fixed location or surface position of the endocardial structure to permit the appropriate procedures to be performed. If sensing procedures are involved, the pair of guiding introducers are placed in the desired location. At that point, the electrical activity of the heart peculiar to that location can be precisely determined by use of an electrophysiology catheter placed within the guiding introducers. Further, as the pair of guiding introducers permit precise location of catheters, an ablation catheter may be placed at a precise location for destruction of the cardiac tissue by the use of energy, for example, radio frequency, thermal, laser or direct current (high energy direct, low energy direct and fulgutronization procedures). The precise placement of the ablation catheter tip on the cardiac tissue is important as there will be no dilution of the energy delivered due to unfocused energy being dissipated over the entire cardiac chamber and lost in the circulating blood by a constant movement of the tip of the ablating catheter. This permits a significantly reduced amount of energy to be applied, while still achieving efficient ablation.
Further, time used to perform the procedure is significantly reduced over procedures where no guiding introducers are used.
It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that this invention be limited except as by the appended claims.
Catheters have become increasingly useful in remote and difficult to reach locations within the body. However, the utilization of these catheters is frequently limited because of the need for the precise placement of the tip of the catheter at a specific location within the body.
2l4o389 Control of the movement of catheters to achieve such precise placement is difficult because of the inherent structure of a catheter. The body of a conventional catheter is long and tubular.
To provide sufficient control of the movement of the catheter, it is necessary that its structure be somewhat rigid. However, the catheter must not be so rigid as to prevent the bending or curving necessary for movement through the vein, artery or other body part to arrive at the specified location. Further, the catheter must not be so rigid as to cause damage to the artery, vein or body part while it is being moved within the body.
While it is important that the catheter not be so rigid as to cause injury, it is also important that there be sufficient rigidity in the catheter to accommodate torque control, i.e., the ability to transmit a twisting force along the length of the catheter. Sufficient torque control enables controlled maneuverability of the catheter by the application of a twisting force at the proximal end of the catheter that is transmitted along the catheter to its distal end. The need for greater torque control often conflicts with the need for reduced rigidity to prevent injury to the body vessel.
Catheters are used increasingly for medical procedures involving the human heart. In these procedures a catheter is typically advanced to the heart through veins or arteries and then is positioned at a specified location within the heart. Typically, the catheter is inserted in an artery or vein in the leg, neck, upper chest or arm of the patient and threaded, often with the aid _ ~1'103~q of a guidewire or introducer, through various arteries or veins until the tip of the catheter reaches the desired location in the heart.
The distal end of a catheter used in such a procedure is sometimes preformed lnto a desired curvature so that by torqulng the catheter about lts longitudinal axis, the catheter can be manlpulated to a desired locatlon wlthln the heart or ln the arteries or veins associated with the heart. For example, U.S.
Patent No. 4,882,777 dlscloses a catheter with a complex curvature at its distal end for use in a specific procedure in the right ventrlcle of a human heart. U.S. Patent No. 5,231,994 dlscloses a guide catheter for gulding a balloon catheter for the dilation of coronary arteries. U.S. Patent No. 4,117,836 discloses a catheter for the selective coronary angiography of the left coronary artery and U.S. Patent Nos. 5,299,574, 5,215,540, 5,016,640 and 4,883,058 disclose catheters for use in selective coronary angiography of the right coronary artery. See also U.S. Patent No. 4,033,031.
Finally, U.S. Patent No. 4,898,591 discusses a catheter with inner and outer layers containing braided portlons. The '591 patent also discloses a number of different curvatures for intravascular catheters.
In addition to single catheters with various curvatures, U.S. Patent No. 4,581,017 dlscloses an inner and outer guide catheter, (numbers 138 and 132), for use with a balloon catheter for treatment of coronary arteries. U.S. Patent No. 5,267,982 discloses a catheter assembly and methods for catheterization of A~
., coronary arteries wherein an inner catheter (50) and outer catheter (52) are used in combination for the treatment of right and left coronary angiographic procedures. See also U.S. Patent No.
4,935,017 which discloses a similar device. U.S. Patent No.
5,290,229 discloses a straight outer sheath and a preformed inner catheter for use in the heart. See also U.S. Patent Nos.
5,304,131, 5,120,323, 4,810,244 and 5,279,546.
Thus, there are a number of patents which disclose catheters with predetermined shapes, designed for use in specific medical procedures generally associated with the heart or the vascular system. Because of the precise physiology of the heart and the vascular system, catheters or introducers with carefully designed shapes for predetermined uses within the human heart and vascular system are important.
The sources of energy used for catheter ablation vary.
Initially, high voltage, direct current (DC) ablation techniques were commonly used. However, because of problems associated with the use of DC current, radio frequency (R.F.) ablation has become a preferred source of energy for the ablation procedures. The use of RF energy for ablation has been disclosed, for example, in U.S.
Patent Nos. 4,945,912, 5,209,229, 5,281,218, 5,242,441, 5,246,438, 5,281,213 and 5,293,868. Other energy sources being considered for ablation of heart tissue include laser, ultrasound, microwave and direct current fulgutronization procedures. Also disclosed have been procedures where the temperature about the catherization probe is modified.
Catheter ablation of accessory pathways associated with Wolfe-Parkinson-White syndrome using a long vascular sheath by both a transseptal and retrograde approach is discussed in Saul, J.P., et al. "Catheter Ablation of accessory Atrioventricular Pathways in Young Patients: Use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approach" Journal of the American College of Cardiology, Vol. 21, no. 3, pps. 571-583 (March 1, 1993). See also Swartz, J.F. "Radiofrequency Endocardial Catheter Ablation of Accessory Atrioventricular Pathway Atrial Insertion Sites" Circulation, Vol. 87, no. 2, pps. 487-499 (February, 1993).
Accordingly, it is an object of this invention to prepare a dual guiding introducer system for selected medical procedures in the left atrium.
It is a further object of this invention to prepare a dual guiding introducer system for use in selected electrophysiology procedures within the left atrium of the heart.
Another object of this invention is to prepare a dual guiding introducer system for use in selected ablation procedures within the left atrium of the heart.
These and other objects are obtained by the design of the guiding introducer system disclosed in the instant invention.
(d) Summary of Invention The instant invention is a guiding introducer system for selected medical procedures in the left atrium. It is comprised of an inner guiding introducer and an outer guiding introducer. A
dilator is preferably used with the guiding introducer system, which dilator may be a transseptal dilator used with a Brockenbrough needle. The inner guiding introducer is a shaped introducer comprised of a first and second section, wherein the first section is a generally elongated straight section which is merged at its distal end with the second section which is a simple curved section. The outer guiding introducer is comprised of a first and second sections, wherein the first section is a generally elongated straight section which is merged at its distal end with the second section which forms a complex curved section. The inner guiding introducer is longer than the outer guiding introducer to permit it to extend out from the lumen of the outer guiding introducer to form various curves and shapes.
(e) Brief Description of the Drawings Figure 1 is a cross-section of the left side of the heart showing the mitral valve and the placement of the guiding introducer system.
Figure 2 is a perspective view of the preferred dilator.
Figure 3 is a perspective view of the inner guiding introducer.
Figure 4 is a perspective view of the outer guiding introducer.
Figure 5 is a perspective view of the inner and outer guiding introducers in combination with the distal end of the inner guiding introducer extended from the distal end of the outer guiding introducer.
-(f) Detailed Description of the Drawings.
A typical human heart includes a right ventricle, a right atrium, left ventricle and left atrium. The right atrium is in fluid commlln;cation with the superior vena cava and the inferior vena cava. The atrioventricular septum separates the right atrium from the right ventricle. The tricuspid valve contained within the atrioventricular septum COmmlln; cates the right atrium with the right ventricle. On the inner wall of the right atrium where it is connected with the left atrium is a recessed portion, the fossa ovalis. See Figure 1. In the heart of a fetus, the fossa ovalis is open, permitting the fetal blood to flow between the right and left atria. In most individuals, this opening closes after birth, but in as many as 25 percent of individuals an opening still remains in the fossa ovalis between the right and left atria.
Between the fossa ovalis and the tricuspid valve is the opening or ostium for the coronary sinus. The coronary sinus is the large epicardial vein which accommodates most of the venous blood which drains from the myocardium into the right atrium.
In the normal heart, contraction and relaxation of the heart muscle (myocardium) takes place in an organized fashion as electro-chemical signals pass sequentially through the myocardium from the atrial to the ventricular tissue along a well defined route which includes the His-Purkinje system. Initial electrical impulses are generated at the sinuatrial (SA) node and conducted to the atrioventricular (AV) node. The AV node lies near the ostium of the coronary sinus in the interatrial septum in the right atrium.
21~038~
The His-Purkinje system begins at the AV node and follows along the membranous interatrial septum toward the tricuspid valve through the atrioventricular septum and into the membranous interventricular septum. At about the middle of the interventricular septum, the His-Purkinje system splits into right and left branches which straddle the summit of the muscular part of the interventricular septum.
Sometimes abnormal rhythms occur in the heart which are referred to as arrhythmia. For example, a common arrhythmia is Wolfe-Parkinson-White syndrome (W-P-W). The cause of W-P-W is generally believed to be the existence of an anomalous conduction pathway or pathways that connects the atrial muscle tissue directly to the ventricular muscle tissue, thus by-passing the normal His-Purkinje system. These pathways are usually located in the fibrous tissue that connects the atrium and the ventricle. In recent years a technique has been developed to destroy these anomalous conduction pathways by delivering energy into the tissue in which the pathways exist. To accomplish this procedure a special electrode catheter is positioned as close as possible to the anomalous conduction pathway to maintain constant tissue contact while energy is delivered to the cardiac tissue to destroy the pathway. This same type of contact with the cardiac tissue is also necessary when mapping or other such procedures are employed relating to these pathways.
One end of these anomalous conduction pathways can be located either in the right atrium or in the left atrium with the other end ~140389 of the pathway located in the corresponding ventricle. When the anomalous conduction pathway is located between the left atrium and the left ventricle, there are two approaches to positioning the catheter near the pathway for the appropriate medical procedure.
One is to introduce the catheter into the femoral artery by a standard introducer sheath and advance it up the aorta, across the aortic valve into the left ventricle and then attempt to position its tip under the mitral valve annulus near the anomalous conduction pathway. This approach is frequently difficult for many reasons, including the structure of the left ventricle, the fact that it requires arterial access and potential problems associated with ablation of ventricular tissue such as the creation of a substrate for a future arrhythmia which could result in sudden cardiac death. The other approach is to introduce a transseptal sheath apparatus, a long single plane curve introducer, into the right femoral vein and advance it through the inferior vena cava into the right atrium. A puncture is then made through the fossa ovalis in the interatrial septum and the apparatus is advanced into the left atrium where the trocar and dilator of the apparatus are removed, leaving the introducer in position in the left atrium.
The mapping or ablation catheter is then inserted through the introducer and into the left atrium and positioned on top of the mitral valve annulus near the anomalous conduction pathway.
Specific positions may be chosen for the mapping or ablation on the left side of the heart, including specifically posteroseptal, posterior, posterolateral, lateral and anterolateral positions "` 2140389 around the mitral valve annulus.
Traditionally, there have been two techniques for locating and ablating anomalous conduction pathways which are situated between the right atrium and right ventricle. Either method can be initiated by advancing a catheter through an access site into a vein in the leg, neck or upper chest.
The first technique, which approaches the pathway from the pathway's ventricular insertion site, involves entering the right atrium from either the inferior or superior vena cava, passing through the tricuspid valve, and advancing toward the apex of the right ventricle. Then the catheter is directed to make a 180 degree turn to reverse its path back up toward the right atrium and locate the accessory pathway under the tricuspid valve apparatus.
The accessory pathway is then ablated from the ventricular insertion site under the tricuspid valve.
The second technique, which approaches the pathway from the atrial insertion site, is to enter the right atrium from the inferior or superior vena cava, and attempt to locate the atrial insertion site of the accessory pathway around the tricuspid valve annulus. The accessory pathway is then ablated from the pathway's atrial insertion site on the atrial aspect of the tricuspid valve.
AV nodal pathways can be located and ablated from the right atrium.
Mere introduction of the catheter into the left atrium is not sufficient to effectively and efficiently perform these medical procedures, especially the mapping or ablation of anomalous ~l l L1 C) 389 conduction pathways. These medical procedures are usually performed using a specific catheter. The medical practitioners monitor the introduction of the catheter and its progress through the vascular system by a fluoroscope. However, such fluoroscopes do not easlly identify the specific features of the heart in general and the critically important structures of the left atrium in specific, thus making placement of the catheter difficult.
This placement is especially difficult as the beating heart is in motion and the catheter will be moving within the left atrium as blood is being pumped through the heart throughout the procedure.
The structure and shape of the guiding introducer of the instant inventlon addresses and solves these problems.
The guiding introducer system for use ln the left atrium is comprised of an inner and an outer guiding introducer. See Figure 5. A dilator is also preferably used wherein the dilator may be a transseptal dilator used with cardiac procedures requiring a Brockenbrough needle for a transseptal puncture and is generally curved. See Flgure 2. Generally the dlstal end is curved in a curve with a radius of about 3.0 to 4.0 in. with an arc of about 20 to about 40 degrees ending in a conventional distal tip. The standard length of the dilator is about 60 to about 80 cm. Alternatively, a different dilator may be used without a Brockenbrough needle.
The inner guiding introducer ls generally comprlsed of two sectlons. See Flgure 3. The first sectlon is a conventional generally elongated hollow straight catheter section of sufficient length for introduction lnto the patient and for manipulation from ~i' ~1~389 the point of lnsertlon to the speclfic deslred location wlthln the heart. Merged wlth the distal end of the flrst section of the guiding introducer, but an lntegral part of the entlre guldlng lntroducer, ls the second sectlon which ls a curved sectlon, curved ln a simple curve wlth a radlus of about 0.5 to about 2.0 ln., preferably about 0.7 to about 1.3 ln. to form an arc of approximately 150 to about 270 degrees, preferably about 170 to about 190 degrees endlng ln a dlstal tlp.
The outer guldlng lntroducer for use ln the left atrium is comprised of a first and second sections. See Figure 4. ~As with the inner guiding introducer, this divlsion into two separate sections is for ease of illustratlon. The gulding introducer is preferably formed in a single procedure with each section an integral part of the overall guiding introducer.) The flrst section ls a conventional, generally elongated hollow straight catheter section of sufflclent length for lntroductlon lnto the patient and for manlpulatlon from the polnt of insertion to the speclflc deslred locatlon wlthln the heart. Merged wlth the dlstal end of the flrst sectlon of the guldlng lntroducer ls the second sectlon whlch ls comprlsed of a compound curved sectlon curvlng both upward and to the rlght (as shown ln Flgure 4). This curved sectlon flrst curves upward ln a curve wlth a radius of about 0.3 to about 0.7 in. with an arc of approximately 40 to about 60 degrees, preferably about 45 to about 55 degrees. At the same tlme as the curved sectlon curves upward, it also curves to the rlght ln a slmple curve wlth a radlus of from about 0.70 to about 1.30 in. and preferably from about 0.80 to about 1.20 ln.
~ 1~038q with an arc of about 30 degrees to about 60 degrees, and preferably from about 40 degrees to about 50 degrees, endlng ln the distal tip of the outer gulding lntroducer.
By extendlng the dlstal tlp of the lnner guldlng introducer away from the dlstal tlp of the outer guldlng lntroducer and by rotatlng the lnner guldlng lntroducer wlth respect to the outer guldlng lntroducer, a varlety of shapes of the overall guldlng lntroducer system are formed to dlrect the mapplng and/or ablatlon catheter toward the site wlthln the atrlum of lnterest. See Flgure 5. These shapes permlt ablatlon procedures wlthln the left atrium to be performed, for example, around the mltral valve annulus ln varlous posltlons such as anterior to anterolateral to lateral to posterolateral to posteroseptal to septal. The various locatlons can be treated by extendlng the inner guldlng introducer further from the outer guidlng lntroducer whlch forms a dlfferent overall shape and/or by rotatlng the lnner guldlng lntroducer wlth respect to the outer guidlng lntroducer. In addltlon, by manlpulatlon of the lnner guidlng introducer withln the outer guiding introducer, additional procedures can be performed withln the left atrlum, for example, for treatment of ectoplc atrial tachycardia or even for certain atrlal flbrlllatlon procedures. Belng able to extend the lnner guidlng introducer withln the outer guiding introducer and to rotate the lnner guldlng introducer within the outer guldlng lntroducer permlts a wlde varlety of overall shapes, whlch ls 69208-4g ~!
~1~0389 particularly useful to the medical practitioners. The medical practitioner is able to determine the relative location of the inner and outer guiding introducers because of tip markers located near the distal tip of both the inner and outer guiding introducers.
The distal tip of both the inner and outer guiding introducers may be, and generally will be, tapered to form a good transition with the dilator.
The relative size of the outer guiding introducer in relation to the inner guiding introducer should be sufficient to permit the inner guiding introducer to be torqued or rotated within the outer guiding introducer without undue restriction on such movement.
Preferably, the difference in size between the inner and outer guiding introducer should be at least about 3 "French" (1 French equals about one-third of a millimeter). For example in one preferred embodiment, the outer guiding introducer is 11 French in size and the inner guiding introducer is 8 French. By this difference in diameter, there is approximately 1 French unit of volume available between the outer surface of the inner guiding introducer and the inner surface of the outer guiding introducer.
Preferably, this volume of space between the inner and outer guiding introducer is filled with a biocompatible solution, such as a saline solution, preferably a heparinized saline solution. This saline solution also provides lubricity to the two guiding introducers, allowing more accurate torquing of the inner guiding introducer within the outer guiding introducer. In addition, it is 214~389 preferable that the structure of both the inner and the outer guiding introducer have a high torsional constant to allow for the full utilization of the various shapes available by rotation and extension of the inner and outer guiding introducer. To permit this high torsional constant, in one preferred embodiment the inner guiding introducer is braided to provide further strength and structural stability.
The guiding introducer may be made of any material suitable for use in humans, which has a memory or permits distortion from and subsequent substantial return to the desired three dimensional or complex multi-planar shape. For the purpose of illustration and not limitation, the internal diameter of the tip of the guiding introducers may vary from about 6 to about 10 "French" Such guiding introducers can accept dilators from about 6 to about 10 French and appropriate guidewires. Obviously if larger, or smaller dilators and catheters are used in conjunction with the guiding introducers of the instant invention, modification can be made in the size of the instant guiding introducers.
The pair of guiding introducers preferably contain one or a multitude of radiopaque tip marker bands near the distal tip of the guiding introducers. Various modifications may be made in the shapes by increasing or decreasing its size or adding additional tip markers.
The inner and outer guiding introducers also preferably contain one or a plurality of vents near the distal tip of the guiding introducers, preferably 3 or 4 or such vents. The vents 038~
are preferably located no more than about 5 to 6 cm. from the tip of the guiding introducers and more preferably 0.5 cm. to about 4.0 cm. from the tip. The size of these vents should be in the range of about 20 to 60 1/1000 of an inch in diameter. These vents are generally designed to prevent air embolisms from entering the guiding introducers caused by the withdrawal of a catheter contained within the guiding introducers in the event the distal tip of one of the guiding introducers is occluded. For example, if the tip of the inner guiding introducer is placed against the myocardium and the catheter located within the inner guiding introducer is withdrawn, a vacuum may be created within the inner guiding introducer if no vents are provided. If such vacuum is formed, air may be forced back into the guiding introducer by the reintroduction of a catheter into the lumen of the guiding introducers. Such air embolism could cause problems to the patient including the possibility of a stroke, heart attack or other such problems common with air embolisms in the heart. The addition of vents near the distal tip of the guiding introducers prevents the formation of such vacuum by permitting fluid, presumably blood, to be drawn into the lumen of the guiding introducers as the catheter is being removed, thus preventing the possibility of formation of an air embolism.
Variances in size or shape of the pair of guiding introducers are also intended to encompass pediatric uses for the pair of guiding introducers of the instant invention, although the preferred use is for adult human hearts. It is well recognized 2i~0389 .~
that pediatric uses may require reductions in size of the various sections of the guiding introducers in particular the first section, but without any significant modification to the shape or curves of the guiding introducers. However, because incremental changes can be made in the overall shape of the pair of guiding introducers, the system can better adjust to differing shapes and sizes of heart than can a single guiding introducer.
In operation, a modified Seldinger technique is normally used for the insertion of a catheter into either an artery or vein of the body. Using this procedure, a small skin incision is made at the appropriate location to facilitate the catheter and dilator passage. The subcutaneous tissue is then dissected, followed by a puncture of the vessel with an appropriate needle with stylet positioned at a relatively shallow angle. The needle is then partially withdrawn and reinserted at a slightly different angle into the vessel, making sure that the needle remains within the vessel. A soft flexible tip of an appropriate sized guidewire is then inserted through and a short distance beyond the needle into the vessel. Firmly holding the guidewire in place, the needle is removed. The guidewire is then advanced through the vessel into the right atrium. With the guidewire in place, the dilator is then placed over the guidewire with the pair of guiding introducers placed over the dilator. The dilator and pair of guiding introducers generally form an assembly to be advanced together along the guidewire into the right atrium. After insertion of the assembly, the guidewire is then withdrawn. A Brockenbrough or 21~0389 -trocar needle is then inserted through the lumen of the dilator to the right atrium to be used to create an opening through the interatrial septum, preferably at the fossa ovalis. The tip rests against the intraatrial septum at the level of the fossa ovalis.
The Brockenbrough needle is then advanced within the dilator to reach the fossa ovalis. After the opening is made through the interatrial septum, the needle, dilator and pair of guiding introducers are advanced into the left atrium. After the pair of guiding introducers are advanced through the interatrial septum into the left atrium, the Brockenbrough or trocar and dilator are removed, leaving the pair of guiding introducers in the left atrium. The catheter to be used for analysis and/or treatment of the anomalous conduction pathways is then advanced through the lumen of the pair of guiding introducers and is placed at an appropriate location near the mitral valve annulus. By extending and withdrawing the inner guiding introducer from the outer guiding introducer and by rotating the inner guiding introducer within the outer guiding introducer, great variances in the overall shape of the guiding introducer system can be achieved.
By movement of the inner guiding introducer within the outer guiding introducer in conjunction with fluoroscopic viewing, the distal portion of the outer guiding introducer can be manipulated to direct the distal end of a catheter placed within the lumen of the inner guiding introducer to a specific internal surface within the left atrium. See Figure 5. In addition, by providing sufficient rigidity, the distal end of the inner guiding catheter 21g~389 can be maintained in that fixed location or surface position of the endocardial structure to permit the appropriate procedures to be performed. If sensing procedures are involved, the pair of guiding introducers are placed in the desired location. At that point, the electrical activity of the heart peculiar to that location can be precisely determined by use of an electrophysiology catheter placed within the guiding introducers. Further, as the pair of guiding introducers permit precise location of catheters, an ablation catheter may be placed at a precise location for destruction of the cardiac tissue by the use of energy, for example, radio frequency, thermal, laser or direct current (high energy direct, low energy direct and fulgutronization procedures). The precise placement of the ablation catheter tip on the cardiac tissue is important as there will be no dilution of the energy delivered due to unfocused energy being dissipated over the entire cardiac chamber and lost in the circulating blood by a constant movement of the tip of the ablating catheter. This permits a significantly reduced amount of energy to be applied, while still achieving efficient ablation.
Further, time used to perform the procedure is significantly reduced over procedures where no guiding introducers are used.
It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that this invention be limited except as by the appended claims.
Claims (16)
1. A guiding introducer system to be used in the left atrium of a human heart comprised of an inner guiding introducer and an outer guiding introducer wherein said guiding introducers are used in combination.
2. The guiding introducer system of Claim 1 wherein a transseptal dilator containing distal and proximal ends is used with the inner and outer guiding introducers, wherein said dilator curves at its distal end in a simple curve with a radius of about
3.0 to about 4.0 in. with an arc of about 20 to about 40 degrees.
3. The guiding introducer system of Claim 1 wherein the inner guiding introducer is comprised of a first and second sections each with proximal and distal ends, wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section is the second section which is a curved section with a radius of about 0.5 to about 2.0 in. to form an arc of approximately 150 to 270 degrees ending in the distal end of the second section of the inner guiding introducer.
3. The guiding introducer system of Claim 1 wherein the inner guiding introducer is comprised of a first and second sections each with proximal and distal ends, wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section is the second section which is a curved section with a radius of about 0.5 to about 2.0 in. to form an arc of approximately 150 to 270 degrees ending in the distal end of the second section of the inner guiding introducer.
4. The guiding introducer system of Claim 1 wherein the outer guiding introducer is comprised of a first and second sections each with proximal and distal ends, wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section is the second section which is comprised of a compound curved portion, curving in a curve with a radius of about 0.3 to about 0.7 in. to form an arc of about 40 to about 60 degrees and at the same time curving in a curve with a radius of about 0.8 in. to about 1.2 in. to form an arc of about 30 to about 60 degrees, ending in the distal end of the second section of the outer guiding introducer.
5. The guiding introducer system of Claim 3 wherein a plurality of vents is provided near the distal end of the second section of the inner guiding introducer.
6. The guiding introducer system of Claim 4 wherein a plurality of vents is provided near the distal end of the second section of the outer guiding introducer.
7. The guiding introducer system of Claim 3 wherein tip markers are contained within the inner guiding introducer.
8. The guiding introducer system of Claim 4 wherein tip markers are contained within the outer guiding introducer.
9. A method for the mapping and/or ablation of anomalous conduction pathways within the left side of the heart comprising (a) introducing into the left side of the heart a guiding introducer system comprised of an inner guiding introducer and an outer guiding introducer, wherein each of the inner and outer guiding introducers contains a lumen passing therethrough, a proximal end and a distal end;
(b) introducing the inner guiding introducer into the lumen of the outer guiding introducer and extending the distal end of said inner guiding introducer through the lumen of the outer guiding introducer;
(c) introducing into the lumen of the inner guiding introducer a catheter for mapping and/or ablation of anomalous conduction pathways, wherein said catheter contains a distal tip and one or more electrodes; and (d) extending said distal tip of the catheter through the lumen of the inner guiding introducer and beyond the distal end of the inner and outer guiding introducers to allow the electrodes of the catheter to map and/or ablate one or more anomalous conduction pathways within the left side of the heart.
(b) introducing the inner guiding introducer into the lumen of the outer guiding introducer and extending the distal end of said inner guiding introducer through the lumen of the outer guiding introducer;
(c) introducing into the lumen of the inner guiding introducer a catheter for mapping and/or ablation of anomalous conduction pathways, wherein said catheter contains a distal tip and one or more electrodes; and (d) extending said distal tip of the catheter through the lumen of the inner guiding introducer and beyond the distal end of the inner and outer guiding introducers to allow the electrodes of the catheter to map and/or ablate one or more anomalous conduction pathways within the left side of the heart.
10. The method of Claim 9 wherein ablation of anomalous conduction pathways utilizes an energy source chosen from radio frequency, thermal, laser or direct current (high energy, low energy or fulgutronization procedures).
11. The method of Claim 10 wherein the energy source used for ablation is radio frequency energy.
12. The method of Claim 9 wherein the inner guiding introducer is comprised of a first and second sections, each with proximal and distal ends wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section is the second section, wherein the second section is a curved section, curved with a radius of about 0.5 to about 2.0 in. to form an arc of approximately 150 degrees to about 270 degrees ending in the distal end of the second section of the inner guiding introducer.
13. The method of Claim 9 wherein the outer guiding introducer is comprised of a first and second sections each with proximal and distal ends, wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section is the second section which is comprised of a compound curved section, curving with a radius of about 0.3 to about 0.7 in. to form an arc of about 40 to about 60 degrees and at the same time curving with a radius of about 0.8 in. to about 1.2 in. to form an arc of approximately 30 degrees to 60 degrees, ending in the distal end of the second end of the outer guiding introducer.
14. A method for the treatment of Wolfe-Parkinson-White syndrome within the left side of the heart comprising (a) introducing into the left side of the heart a guiding introducer system comprised of an inner and an outer guiding introducer, wherein each of the inner and outer guiding introducers contains a lumen passing therethrough, a proximal and distal end;
(b) introducing the inner guiding introducer into the lumen of the outer guiding introducer and extending the distal end of said inner guiding introducer through the lumen of the outer guiding introducer until the distal end of the inner guiding introducer is extended from the distal end of the outer guiding introducer;
(c) introducing into the lumen of the inner guiding introducer a catheter, wherein said catheter contains a distal tip and one or more electrodes; and (d) extending said distal tip of the catheter through the lumen of the inner guiding introducer and beyond the distal end of the inner and outer guiding introducer to permit the electrodes of the catheter to ablate anomalous conduction pathways within the left side of the heart as a treatment for Wolfe-Parkinson-White syndrome.
(b) introducing the inner guiding introducer into the lumen of the outer guiding introducer and extending the distal end of said inner guiding introducer through the lumen of the outer guiding introducer until the distal end of the inner guiding introducer is extended from the distal end of the outer guiding introducer;
(c) introducing into the lumen of the inner guiding introducer a catheter, wherein said catheter contains a distal tip and one or more electrodes; and (d) extending said distal tip of the catheter through the lumen of the inner guiding introducer and beyond the distal end of the inner and outer guiding introducer to permit the electrodes of the catheter to ablate anomalous conduction pathways within the left side of the heart as a treatment for Wolfe-Parkinson-White syndrome.
15. The method for the treatment of Wolfe-Parkinson-White syndrome of Claim 14 wherein the inner guiding introducer is comprised of a first and second sections each with proximal and distal ends, wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section of said inner guiding introducer is the second section which is a curved section, curved with a radius of about 0.5 in.
to about 1.5 in. to form an arc of approximately 150 to 270 degrees, ending in the distal end of the second section of the inner guiding introducer.
to about 1.5 in. to form an arc of approximately 150 to 270 degrees, ending in the distal end of the second section of the inner guiding introducer.
16. The method for the treatment of Wolfe-Parkinson-White syndrome of Claim 14 wherein the outer guiding introducer is comprised of a first and second sections each with proximal and distal ends, wherein the first section is a generally elongated straight section, wherein merged with the distal end of said first section is the second section which is comprised of a compound curved section, curving with a radius of about 0.3 to about 0.7 in. to form an arc of about 40 to about 60 degrees and at the same time curving with a radius of about 0.8 in. to about 1.2 in. to form an arc of approximately 30 degrees to 60 degrees, ending in the distal end of the second section of the outer guiding introducer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/333,791 US5564440A (en) | 1993-11-03 | 1994-11-03 | Method for mopping and/or ablation of anomalous conduction pathways |
| US08/333,791 | 1994-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2140389A1 true CA2140389A1 (en) | 1996-05-04 |
Family
ID=23304264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002140389A Abandoned CA2140389A1 (en) | 1994-11-03 | 1995-01-17 | Guiding introducer system for use in left atrium |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US5564440A (en) |
| EP (1) | EP0714671B1 (en) |
| JP (1) | JP3259249B2 (en) |
| AT (1) | ATE268621T1 (en) |
| CA (1) | CA2140389A1 (en) |
| DE (1) | DE69533125T2 (en) |
Families Citing this family (160)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
| US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
| US5722400A (en) * | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
| US5640955A (en) * | 1995-02-14 | 1997-06-24 | Daig Corporation | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
| US6090084A (en) * | 1994-07-08 | 2000-07-18 | Daig Corporation | Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia |
| US5814029A (en) * | 1994-11-03 | 1998-09-29 | Daig Corporation | Guiding introducer system for use in ablation and mapping procedures in the left ventricle |
| US6540755B2 (en) | 1995-02-14 | 2003-04-01 | Daig Corporation | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
| US5897553A (en) | 1995-11-02 | 1999-04-27 | Medtronic, Inc. | Ball point fluid-assisted electrocautery device |
| US5891057A (en) * | 1995-10-04 | 1999-04-06 | Chaisson; Gary A. | Carotid artery angioplasty guiding system |
| US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
| US6200303B1 (en) | 1997-04-30 | 2001-03-13 | Beth Israel Deaconess Medical Center, Inc. | Method and kit for transvenously accessing the pericardial space via the right atrium |
| US5968010A (en) * | 1997-04-30 | 1999-10-19 | Beth Israel Deaconess Medical Center, Inc. | Method for transvenously accessing the pericardial space via the right atrium |
| US20040215168A1 (en) * | 1997-04-30 | 2004-10-28 | Beth Israel Deaconess Medical Center | Kit for transvenously accessing the pericardial space via the right atrium |
| US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
| US6024740A (en) * | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
| US6012457A (en) * | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
| US5938660A (en) * | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
| US6251109B1 (en) * | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
| US6652515B1 (en) * | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
| US6997925B2 (en) * | 1997-07-08 | 2006-02-14 | Atrionx, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
| US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
| US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
| US6245064B1 (en) | 1997-07-08 | 2001-06-12 | Atrionix, Inc. | Circumferential ablation device assembly |
| US6500174B1 (en) * | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
| US6164283A (en) * | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
| US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
| US6080151A (en) | 1997-07-21 | 2000-06-27 | Daig Corporation | Ablation catheter |
| WO1999018870A1 (en) * | 1997-10-10 | 1999-04-22 | Hearten Medical, Inc. | A balloon catheter for causing thermal trauma to a patent foramen ovale and method of using the balloon catheter |
| WO1999018871A1 (en) * | 1997-10-10 | 1999-04-22 | Hearten Medical, Inc. | A catheter for causing thermal trauma to a patent foramen ovale and method of using the catheter |
| US6200315B1 (en) | 1997-12-18 | 2001-03-13 | Medtronic, Inc. | Left atrium ablation catheter |
| US6066126A (en) * | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
| US6006137A (en) * | 1998-03-06 | 1999-12-21 | Medtronic, Inc. | Method for single elecrode bi-atrial pacing |
| US6522930B1 (en) * | 1998-05-06 | 2003-02-18 | Atrionix, Inc. | Irrigated ablation device assembly |
| US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
| US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
| US6607502B1 (en) | 1998-11-25 | 2003-08-19 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
| US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
| US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
| US20050010095A1 (en) * | 1999-04-05 | 2005-01-13 | Medtronic, Inc. | Multi-purpose catheter apparatus and method of use |
| ES2279757T3 (en) | 1999-05-11 | 2007-09-01 | Atrionix, Inc. | BALL ANCHORING THREAD. |
| US6758830B1 (en) | 1999-05-11 | 2004-07-06 | Atrionix, Inc. | Catheter positioning system |
| US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
| US6447443B1 (en) * | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
| US6562049B1 (en) * | 2000-03-01 | 2003-05-13 | Cook Vascular Incorporated | Medical introducer apparatus |
| US6702810B2 (en) | 2000-03-06 | 2004-03-09 | Tissuelink Medical Inc. | Fluid delivery system and controller for electrosurgical devices |
| US8048070B2 (en) | 2000-03-06 | 2011-11-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices, systems and methods |
| US7811282B2 (en) | 2000-03-06 | 2010-10-12 | Salient Surgical Technologies, Inc. | Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof |
| US6689131B2 (en) | 2001-03-08 | 2004-02-10 | Tissuelink Medical, Inc. | Electrosurgical device having a tissue reduction sensor |
| US6558385B1 (en) | 2000-09-22 | 2003-05-06 | Tissuelink Medical, Inc. | Fluid-assisted medical device |
| US6650923B1 (en) | 2000-04-13 | 2003-11-18 | Ev3 Sunnyvale, Inc. | Method for accessing the left atrium of the heart by locating the fossa ovalis |
| US7056294B2 (en) * | 2000-04-13 | 2006-06-06 | Ev3 Sunnyvale, Inc | Method and apparatus for accessing the left atrial appendage |
| US6932811B2 (en) | 2000-04-27 | 2005-08-23 | Atricure, Inc. | Transmural ablation device with integral EKG sensor |
| US6905498B2 (en) | 2000-04-27 | 2005-06-14 | Atricure Inc. | Transmural ablation device with EKG sensor and pacing electrode |
| US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
| US20020107514A1 (en) * | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
| EP1296598B1 (en) * | 2000-05-16 | 2007-11-14 | Atrionix, Inc. | Apparatus incorporating an ultrasound transducer on a delivery member |
| AU6682401A (en) | 2000-06-13 | 2001-12-24 | Atrionix Inc | Surgical ablation probe for forming a circumferential lesion |
| US7740623B2 (en) | 2001-01-13 | 2010-06-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
| US20040138621A1 (en) | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
| US7175734B2 (en) * | 2001-05-03 | 2007-02-13 | Medtronic, Inc. | Porous medical catheter and methods of manufacture |
| US20070112358A1 (en) * | 2001-09-06 | 2007-05-17 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
| US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
| US6776784B2 (en) * | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
| US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
| US20060052821A1 (en) * | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
| US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
| US6702835B2 (en) * | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
| US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
| US20040092806A1 (en) * | 2001-12-11 | 2004-05-13 | Sagon Stephen W | Microelectrode catheter for mapping and ablation |
| US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
| US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
| US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
| US6932804B2 (en) | 2003-01-21 | 2005-08-23 | The Regents Of The University Of California | System and method for forming a non-ablative cardiac conduction block |
| US6866662B2 (en) | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
| US7291161B2 (en) | 2002-10-02 | 2007-11-06 | Atricure, Inc. | Articulated clamping member |
| WO2004039416A2 (en) | 2002-10-29 | 2004-05-13 | Tissuelink Medical, Inc. | Fluid-assisted electrosurgical scissors and methods |
| US7317950B2 (en) | 2002-11-16 | 2008-01-08 | The Regents Of The University Of California | Cardiac stimulation system with delivery of conductive agent |
| US20040102829A1 (en) * | 2002-11-22 | 2004-05-27 | Bonner Matthew D. | Multiple bend catheter for delivering a lead to a heart |
| US7195628B2 (en) * | 2002-12-11 | 2007-03-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Atrial fibrillation therapy with pulmonary vein support |
| US7387629B2 (en) | 2003-01-21 | 2008-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
| US7257450B2 (en) * | 2003-02-13 | 2007-08-14 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue |
| US8021359B2 (en) * | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
| US7288092B2 (en) | 2003-04-23 | 2007-10-30 | Atricure, Inc. | Method and apparatus for ablating cardiac tissue with guide facility |
| US20050038410A1 (en) * | 2003-04-23 | 2005-02-17 | Friedman Paul A. | Rotatable infusion sheath apparatus |
| US20040220461A1 (en) * | 2003-04-29 | 2004-11-04 | Yitzhack Schwartz | Transseptal facilitation using sheath with electrode arrangement |
| US7789877B2 (en) * | 2003-07-02 | 2010-09-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode arrangement |
| US7247269B2 (en) * | 2003-07-21 | 2007-07-24 | Biosense Webster, Inc. | Method for making a spiral array ultrasound transducer |
| US7670335B2 (en) | 2003-07-21 | 2010-03-02 | Biosense Webster, Inc. | Ablation device with spiral array ultrasound transducer |
| US7229437B2 (en) * | 2003-09-22 | 2007-06-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device having integral traces and formed electrodes |
| US8147486B2 (en) * | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
| US7234225B2 (en) * | 2003-09-22 | 2007-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method for manufacturing medical device having embedded traces and formed electrodes |
| US20050149097A1 (en) * | 2003-12-30 | 2005-07-07 | Regnell Sandra J. | Transseptal needle |
| ATE507789T1 (en) * | 2003-12-31 | 2011-05-15 | Biosense Webster Inc | COMPREHENSIVE ABLATION DEVICE ASSEMBLY HAVING DUAL EXPANDABLE ELEMENTS |
| US7727232B1 (en) | 2004-02-04 | 2010-06-01 | Salient Surgical Technologies, Inc. | Fluid-assisted medical devices and methods |
| US20050187545A1 (en) * | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
| WO2005084563A1 (en) * | 2004-02-27 | 2005-09-15 | Cook Vascular Incorporated | Device for removing an elongated structure implanted in biological tissue |
| US7530980B2 (en) | 2004-04-14 | 2009-05-12 | Atricure, Inc | Bipolar transmural ablation method and apparatus |
| US8801746B1 (en) | 2004-05-04 | 2014-08-12 | Covidien Lp | System and method for delivering a left atrial appendage containment device |
| US20050273096A1 (en) * | 2004-05-27 | 2005-12-08 | Roop John A | Anchoring introducer sheath with distal slots for catheter delivery and translation |
| WO2005120376A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Ablation device with jaws |
| US7678081B2 (en) * | 2004-07-12 | 2010-03-16 | Pacesetter, Inc. | Methods and devices for transseptal access |
| CA2580353A1 (en) | 2004-09-13 | 2006-06-08 | Biosense Webster, Inc. | Ablation device with phased array ultrasound transducer |
| US7344515B2 (en) * | 2004-09-17 | 2008-03-18 | Medtronic Vascular, Inc. | Guiding catheter with embolic protection by proximal occlusion |
| US20060064056A1 (en) * | 2004-09-17 | 2006-03-23 | James Coyle | Guiding catheter assembly for embolic protection by proximal occlusion |
| US8029470B2 (en) * | 2004-09-30 | 2011-10-04 | Pacesetter, Inc. | Transmembrane access systems and methods |
| US20060079787A1 (en) * | 2004-09-30 | 2006-04-13 | Whiting James S | Transmembrane access systems and methods |
| US20070083168A1 (en) * | 2004-09-30 | 2007-04-12 | Whiting James S | Transmembrane access systems and methods |
| US7473252B2 (en) * | 2004-10-07 | 2009-01-06 | Coaptus Medical Corporation | Systems and methods for shrinking and/or securing cardiovascular tissue |
| US8273285B2 (en) | 2005-01-10 | 2012-09-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable catheter and methods of making the same |
| US20060247911A1 (en) * | 2005-04-28 | 2006-11-02 | Schweitzer Engineering Labs., Inc. | Systems and methods for learning and mimicking the communications of intelligent electronic devices |
| US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
| US20060270900A1 (en) * | 2005-05-26 | 2006-11-30 | Chin Albert K | Apparatus and methods for performing ablation |
| US8579936B2 (en) * | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
| US20070021767A1 (en) | 2005-07-25 | 2007-01-25 | Breznock Eugene M | Steerable endoluminal punch |
| US7846179B2 (en) * | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
| US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
| US7682304B2 (en) * | 2005-09-21 | 2010-03-23 | Medtronic, Inc. | Composite heart valve apparatus manufactured using techniques involving laser machining of tissue |
| US8355801B2 (en) * | 2005-09-26 | 2013-01-15 | Biosense Webster, Inc. | System and method for measuring esophagus proximity |
| US20070093805A1 (en) * | 2005-10-17 | 2007-04-26 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue, including via asymmetric electrodes |
| US20070185479A1 (en) * | 2006-02-06 | 2007-08-09 | Liming Lau | Methods and devices for performing ablation and assessing efficacy thereof |
| EP1984072B1 (en) | 2006-02-13 | 2017-07-19 | Cook Medical Technologies LLC | Device for removing lumenless leads |
| US8273016B2 (en) * | 2006-03-10 | 2012-09-25 | Biosense Webster, Inc. | Esophagus isolation device |
| US20070225697A1 (en) * | 2006-03-23 | 2007-09-27 | Ketan Shroff | Apparatus and methods for cardiac ablation |
| US20070299438A1 (en) * | 2006-06-23 | 2007-12-27 | Holzbaur Michael C | Torque transfer agent for introducer and method |
| US7699845B2 (en) * | 2006-06-23 | 2010-04-20 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation device and method with connector |
| US20070299403A1 (en) * | 2006-06-23 | 2007-12-27 | Crowe John E | Directional introducer |
| US20080039879A1 (en) * | 2006-08-09 | 2008-02-14 | Chin Albert K | Devices and methods for atrial appendage exclusion |
| US8728073B2 (en) | 2006-10-10 | 2014-05-20 | Biosense Webster, Inc. | Multi-region staged inflation balloon |
| US9314298B2 (en) | 2007-04-17 | 2016-04-19 | St. Jude Medical, Atrial Fibrillation Divisions, Inc. | Vacuum-stabilized ablation system |
| US8597288B2 (en) * | 2008-10-01 | 2013-12-03 | St. Jude Medical, Artial Fibrillation Division, Inc. | Vacuum-stabilized ablation system |
| WO2009045265A1 (en) | 2007-10-05 | 2009-04-09 | Maquet Cardiovascular, Llc | Devices and methods for minimally-invasive surgical procedures |
| CA2703732A1 (en) * | 2007-11-07 | 2009-05-14 | Ovalis, Inc. | Systems, devices and methods for achieving transverse orientation in the treatment of septal defects |
| US20090209986A1 (en) * | 2008-02-15 | 2009-08-20 | Stewart Michael C | Devices, Tools and Methods for Atrial Appendage Exclusion |
| JP2011520570A (en) * | 2008-05-20 | 2011-07-21 | オバリス， インコーポレイテッド | Wire-like and other devices for the treatment of septal defects and systems and methods for delivering the same |
| US8317810B2 (en) | 2008-12-29 | 2012-11-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Tissue puncture assemblies and methods for puncturing tissue |
| US8388549B2 (en) | 2008-12-29 | 2013-03-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Anatomical thermal sensing device and method |
| US10058382B2 (en) | 2008-12-30 | 2018-08-28 | Biosense Webster, Inc. | Catheter with protective barrier member |
| JP2011000389A (en) * | 2009-06-22 | 2011-01-06 | Goodman Co Ltd | Medical instrument |
| US8696620B2 (en) | 2010-07-30 | 2014-04-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter with a mechanism for omni-directional deflection of a catheter shaft |
| MX2013004235A (en) | 2010-10-25 | 2013-05-30 | Medtronic Ardian Luxembourg | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods. |
| US8961550B2 (en) | 2012-04-17 | 2015-02-24 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
| ES2614272T3 (en) | 2012-05-11 | 2017-05-30 | Medtronic Ardian Luxembourg S.à.r.l. | Multiple electrode catheter assemblies for renal neuromodulation and associated systems and methods |
| US9095321B2 (en) | 2012-11-21 | 2015-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices having integral multi-helical balloons and methods of making the same |
| CN104968390B (en) | 2012-12-06 | 2019-04-23 | 印第安维尔斯医疗公司 | Steerable seal wire and application method |
| US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
| US20150073515A1 (en) | 2013-09-09 | 2015-03-12 | Medtronic Ardian Luxembourg S.a.r.I. | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
| US10568686B2 (en) | 2013-11-21 | 2020-02-25 | Biosense Webster (Israel) Ltd. | Multi-electrode balloon catheter with circumferential and point electrodes |
| CN106232043B (en) | 2014-04-24 | 2019-07-23 | 美敦力阿迪安卢森堡有限公司 | Nerve modulation conduit and relevant system and method with braiding axle |
| US9993266B2 (en) | 2014-09-13 | 2018-06-12 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
| US10485579B2 (en) | 2016-02-25 | 2019-11-26 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
| US11382654B2 (en) * | 2016-02-25 | 2022-07-12 | Indian Wells Medical, Inc. | Steerable endoluminal punch with cutting stylet |
| US10729457B2 (en) | 2016-02-25 | 2020-08-04 | Indian Wells Medical, Inc. | Steerable endoluminal punch with cutting stylet |
| US10786655B2 (en) | 2016-03-14 | 2020-09-29 | Indian Wells Medical, Inc. | Steerable guidewire and method of use |
| US10966753B2 (en) * | 2016-10-14 | 2021-04-06 | Pacesetter, Inc. | Catheter-based system for delivery and retrieval of a leadless pacemaker |
| EP3614933A1 (en) | 2017-04-27 | 2020-03-04 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
| WO2019195282A1 (en) | 2018-04-02 | 2019-10-10 | Cardiac Pacemakers Inc | Bundle of his lead delivery catheter, system and method |
| WO2020041437A1 (en) | 2018-08-21 | 2020-02-27 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
| EP3998962A1 (en) | 2019-07-17 | 2022-05-25 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with continuous covering |
| CN114340516A (en) | 2019-08-30 | 2022-04-12 | 波士顿科学医学有限公司 | Left atrial appendage implant with sealing disk |
| WO2021195085A1 (en) | 2020-03-24 | 2021-09-30 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE390886B (en) * | 1975-06-23 | 1977-01-31 | Siemens Elema Ab | CATHETER FOR SELECTIVE CORONAR ARTERIOGRAPHY OF LEFT CORONAR SPECIES |
| US4033331A (en) * | 1975-07-17 | 1977-07-05 | Guss Stephen B | Cardiac catheter and method of using same |
| US4581017B1 (en) * | 1983-03-07 | 1994-05-17 | Bard Inc C R | Catheter systems |
| US4569347A (en) * | 1984-05-30 | 1986-02-11 | Advanced Cardiovascular Systems, Inc. | Catheter introducing device, assembly and method |
| US4790331A (en) * | 1986-12-02 | 1988-12-13 | Sherwood Medical Company | Method for placement of catheter in a blood vessel |
| EP0277366A1 (en) * | 1987-01-06 | 1988-08-10 | Advanced Cardiovascular Systems, Inc. | Guiding catheter assembly and method for making it |
| US4882777A (en) * | 1987-04-17 | 1989-11-21 | Narula Onkar S | Catheter |
| US5231994A (en) * | 1987-10-27 | 1993-08-03 | Dietrich Harmjanz | Hose or tubular guide catheter |
| US4810244B1 (en) * | 1987-12-17 | 1998-06-16 | Thomas C Allen | Trocar assembly for drawing fluids from a body part |
| US4883058A (en) * | 1988-01-06 | 1989-11-28 | Sherwood Medical Company | Right coronary angiographic method |
| US5016640A (en) * | 1988-01-06 | 1991-05-21 | Sherwood Medical Company | Angiographic catheter for use in the right coronary artery |
| US4935017A (en) * | 1988-04-29 | 1990-06-19 | C. R. Bard, Inc. | Variable shaped catheter system and method for catheterization |
| US4898591A (en) * | 1988-08-09 | 1990-02-06 | Mallinckrodt, Inc. | Nylon-PEBA copolymer catheter |
| DE3931350A1 (en) * | 1989-09-20 | 1991-03-28 | Kaltenbach Martin | GUIDE SLEEVE FOR IMPORTING CATHETERS |
| US5120323A (en) * | 1990-01-12 | 1992-06-09 | Schneider (Usa) Inc. | Telescoping guide catheter system |
| US5279546A (en) * | 1990-06-27 | 1994-01-18 | Lake Region Manufacturing Company, Inc. | Thrombolysis catheter system |
| US5304131A (en) * | 1991-07-15 | 1994-04-19 | Paskar Larry D | Catheter |
| US5290229A (en) * | 1991-07-15 | 1994-03-01 | Paskar Larry D | Transformable catheter and method |
| US5215540A (en) * | 1992-01-31 | 1993-06-01 | St. Jude Medical, Inc. | Right coronary catheter |
| US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
| US5427119A (en) * | 1993-11-03 | 1995-06-27 | Daig Corporation | Guiding introducer for right atrium |
-
1994
- 1994-11-03 US US08/333,791 patent/US5564440A/en not_active Expired - Lifetime
-
1995
- 1995-01-17 CA CA002140389A patent/CA2140389A1/en not_active Abandoned
- 1995-02-14 DE DE69533125T patent/DE69533125T2/en not_active Expired - Fee Related
- 1995-02-14 EP EP95101983A patent/EP0714671B1/en not_active Expired - Lifetime
- 1995-02-14 AT AT95101983T patent/ATE268621T1/en not_active IP Right Cessation
- 1995-10-20 JP JP27289595A patent/JP3259249B2/en not_active Expired - Lifetime
-
1996
- 1996-02-08 US US08/597,392 patent/US5725512A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3259249B2 (en) | 2002-02-25 |
| US5564440A (en) | 1996-10-15 |
| ATE268621T1 (en) | 2004-06-15 |
| US5725512A (en) | 1998-03-10 |
| EP0714671B1 (en) | 2004-06-09 |
| EP0714671A3 (en) | 1997-05-28 |
| EP0714671A2 (en) | 1996-06-05 |
| DE69533125T2 (en) | 2005-06-16 |
| DE69533125D1 (en) | 2004-07-15 |
| JPH08252317A (en) | 1996-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0714671B1 (en) | Guiding introducer system for use in left atrium | |
| EP0714672B1 (en) | Guiding introducer system for use in right atrium | |
| US5715818A (en) | Method of using a guiding introducer for left atrium | |
| US6203531B1 (en) | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach | |
| US5640955A (en) | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach | |
| US6540755B2 (en) | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach | |
| US5427119A (en) | Guiding introducer for right atrium | |
| US5833673A (en) | Guiding introducer system for use in the treatment of left ventricular tachycardia | |
| US5879296A (en) | Guiding introducers for use in the treatment of left ventricular tachycardia | |
| US7248913B2 (en) | Guiding introducer system for use in medical procedures in the left ventricle | |
| US5785706A (en) | Nonsurgical mapping and treatment of cardiac arrhythmia using a catheter contained within a guiding introducer containing openings | |
| US5814027A (en) | Guiding introducer used for medical procedures within the right ventricle associated with the right ventricular outflow track | |
| US5947938A (en) | Process for the nonsurgical mapping and/or treatment of ectopic atrial tachycardia using a guiding introducer | |
| EP0738518A2 (en) | Guiding introducers used for medical procedures within the right ventricle associated with the tricuspid valve | |
| EP0737486A2 (en) | Guiding introducer used for medical procedures within the right ventricle associated with the right ventricular outflow track | |
| EP0727238A2 (en) | Guiding introducer system for use in the treatment of accessory pathways around the mitral valve using a retrograde approach | |
| WO1999025411A1 (en) | Catheter guiding introducers for use in pediatric hearts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |